Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
JAK2 Targeted Mutation Analysis (V617F) Genetics Center United States | 3 | 1 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
UCSF Molecular Diagnostics Laboratory UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 4 | 52 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
CALR - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
MPL - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Genome-Nilou Lab Iran | 45 | 34 |
|
Invitae Inborn Errors of Immunity and Cytopenias Panel Invitae United States | 755 | 562 |
|
Invitae Inherited Platelet Disorders Including Thrombocytopenia Panel Invitae United States | 70 | 50 |
|
Invitae Familial Essential Thrombocythemia Panel Invitae United States | 9 | 3 |
|
Myeloid NextGen Sequencing Assay with Calreticulin Exon 9 Mutation PathGroup United States | 16 | 65 |
|
Myeloid NextGen Sequencing Assay PathGroup United States | 16 | 65 |
|
Myeloid NextGen Sequencing Assay with FLT3 ITD and TKD Analysis PathGroup United States | 16 | 65 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Comprehensive Myeloid Profile + CALR PCR + FLT3 PCR PathGroup United States | 16 | 65 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 250 | 155 |
|
Inherited Bone Marrow Failure Panel PreventionGenetics, part of Exact Sciences United States | 267 | 186 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.